| Nasal vaccination with N-trimethyl chitosan and PLGA based nanoparticles: nanoparticle characteristics determine quality and strength of the antibody response in mice against … B Slütter, S Bal, C Keijzer, R Mallants, N Hagenaars, I Que, E Kaijzel, ... Vaccine 28 (38), 6282-6291, 2010 | 234 | 2010 |
| Rational design of nasal vaccines B Slütter, N Hagenaars, W Jiskoot Journal of drug targeting 16 (1), 1-17, 2008 | 163 | 2008 |
| Head-to-head comparison of four nonadjuvanted inactivated cell culture-derived influenza vaccines: effect of composition, spatial organization and immunization route on the … N Hagenaars, E Mastrobattista, H Glansbeek, J Heldens, ... Vaccine 26 (51), 6555-6563, 2008 | 87 | 2008 |
| Role of trimethylated chitosan (TMC) in nasal residence time, local distribution and toxicity of an intranasal influenza vaccine N Hagenaars, M Mania, P de Jong, I Que, R Nieuwland, B Slütter, ... Journal of controlled release 144 (1), 17-24, 2010 | 72 | 2010 |
| Relationship between structure and adjuvanticity of N,N,N-trimethyl chitosan (TMC) structural variants in a nasal influenza vaccine N Hagenaars, RJ Verheul, I Mooren, PH de Jong, E Mastrobattista, ... Journal of controlled Release 140 (2), 126-133, 2009 | 67 | 2009 |
| Physicochemical and immunological characterization of N, N, N-trimethyl chitosan-coated whole inactivated influenza virus vaccine for intranasal administration N Hagenaars, E Mastrobattista, RJ Verheul, I Mooren, HL Glansbeek, ... Pharmaceutical research 26, 1353-1364, 2009 | 66 | 2009 |
| A step-by-step approach to study the influence of N-acetylation on the adjuvanticity of N, N, N-trimethyl chitosan (TMC) in an intranasal nanoparticulate influenza virus vaccine RJ Verheul, N Hagenaars, T van Es, EVB van Gaal, PH de Jong, S Bruijns, ... European journal of pharmaceutical sciences 45 (4), 467-474, 2012 | 21 | 2012 |
| Improving the evaluation of worldwide biomedical research output: classification method and standardised bibliometric indicators by disease L van de Laar, T de Kruif, L Waltman, I Meijer, A Gupta, N Hagenaars BMJ open 8 (6), e020818, 2018 | 6 | 2018 |
| Towards an intranasal influenza vaccine based on whole inactivated influenza virus with N, N, N-trimethyl chitosan as adjuvant N Hagenaars Utrecht University, 2009 | 2 | 2009 |
| The relationship between publication volume of biomedical research and burden of disease N Hagenaars, T de Kruif, L van de Laar, L Waltman, I Meijer, M Levi, ... OSF Preprints, 2019 | 1 | 2019 |
| Quantifying the biomedical research agenda of the Netherlands TM de Kruif, LA van de Laar, N Hagenaars Nederlands Tijdschrift Voor Geneeskunde 161, D1333-D1333, 2017 | | 2017 |
| MATURATION OF HUMAN MONOCYTE DERIVED DENDRITIC CELLS BY TRIMETHYL CHITOSAN IS CORRELATED WITH ITS N-ACETYL GLUCOSAMINE (GLCNAC) CONTENT RJ Verheul, N Hagenaars, T van Es, S Bruins, B Slütter, WE Hennink, ... TAILORABLE TRIMETHYL CHITOSANS AS ADJUVANT FOR INTRANASAL IMMUNIZATION, 113, 2010 | | 2010 |
| Colloidal stability of N, N, N-trimethyl chitosan-whole inactivated influenza virus formulations N Hagenaars, P de Jong, R Verheul, E Mastrobattista, W Jiskoot Towards an intranasal influenza vaccine, 149, 2009 | | 2009 |
| Head-to-head comparison of four nonadjuvanted inactivated cell culture-derived influenza vaccines N Hagenaars, E Mastrobattista, H Glansbeek, J Heldens, ... Towards an intranasal influenza vaccine 26 (51), 53, 2009 | | 2009 |
| A step-by-step approach to study the influence of N-acetylation on the adjuvanticity of TMC N Hagenaars, R Verheul, T van Es, E van Gaal, S Bruijns, P de Jong, ... Towards an intranasal influenza vaccine, 133, 2009 | | 2009 |
